Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of research into the endocannabinoid system that followed, Professor Mechoulam is often called the “Godfather of cannabis research”. 
Since his research began in the 1960s, Professor Mechoulam has received numerous academic awards. Most recently he received The Harvey Prize from the Technion Israel Institute of Technology in the Human Health category. It’s a pretty big deal when you consider more than 30% of Harvey laureates since 1986 have gone onto receive the Nobel prize. 
Professor Mechoulam has presented at every CannMed event, either in person or via submitted video, and is the chair of our Scientific Advisory Board. 
In our conversation, we discuss: 

Professor Mechoulam’s incredible career 
The disappointing lack of cannabis medicine clinical trials 
The surprising fact that the two major endogenous cannabinoids (anandamide and 2AG) have never been administered to humans 
The challenge of researching the entourage effect 
The benefits of cannabinoid acids 
The newly discovered anandamide-like compounds that could be used to treat addiction 
And more 

Thanks to our Sponsor: Cannabis Science and Technology
Cannabis Science and Technology focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control/assurance, extraction, cultivation, and processing/manufacturing. In October Cannabis Science & Technology launched a new brand, Cannabis Patient Care, which is an educational resource for patients, doctors, nurses, pharmacists, and caregivers on the latest research, benefits, and treatment options cannabis provides for a variety of illnesses.
Learn more at cannabissciencetech.com
Additional Resources

Professor Mechoulam’s CannMed presentations: 2016 | 2017 | 2018 | 2019
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
The chemistry of endocannabinoids
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

Ver todos los episodios